Search

Your search keyword '"Sural Nerve drug effects"' showing total 222 results

Search Constraints

Start Over You searched for: Descriptor "Sural Nerve drug effects" Remove constraint Descriptor: "Sural Nerve drug effects"
222 results on '"Sural Nerve drug effects"'

Search Results

1. Analgesic effect of a cholinergic agonist (carbachol) in a sural nerve ligation-induced hypersensitivity mouse model.

2. How different experimental models of secondary hyperalgesia change the nociceptive flexion reflex.

Catalog

Books, media, physical & digital resources

3. Tocotrienol-Rich Vitamin E (Tocovid) Improved Nerve Conduction Velocity in Type 2 Diabetes Mellitus Patients in a Phase II Double-Blind, Randomized Controlled Clinical Trial.

4. The effects of mepolizumab on peripheral circulation and neurological symptoms in eosinophilic granulomatosis with polyangiitis (EGPA) patients.

5. Resveratrol mediates mechanical allodynia through modulating inflammatory response via the TREM2-autophagy axis in SNI rat model.

6. Dexmedetomidine attenuates P2X4 and NLRP3 expression in the spine of rats with diabetic neuropathic pain.

7. Mid-term oral isotretinoin therapy causes a predominantly sensory demyelinating neuropathy.

8. Antiallodynic Effects of Endomorphin-1 and Endomorphin-2 in the Spared Nerve Injury Model of Neuropathic Pain in Mice.

9. Minocycline attenuates the development of diabetic neuropathy by inhibiting spinal cord Notch signaling in rat.

10. Clinical application of ghrelin for diabetic peripheral neuropathy.

11. Predicting the Response to Intravenous Immunoglobulins in an Animal Model of Chronic Neuritis.

12. [Clinical and electrophysiological studies of oxaliplatin-induced peripheral neuropathy].

13. Topical Citrullus colocynthis (bitter apple) extract oil in painful diabetic neuropathy: A double-blind randomized placebo-controlled clinical trial.

14. The Metabolic Syndrome and Microvascular Complications in a Murine Model of Type 2 Diabetes.

15. N-hexane neuropathy with vertigo and cold allodynia in a silk screen printer: A case study.

16. Amelioration of cisplatin-induced experimental peripheral neuropathy by a small molecule targeting p75 NTR.

17. Depressing effect of electroacupuncture on the spinal non-painful sensory input of the rat.

18. Responses of intact and injured sural nerve fibers to cooling and menthol.

19. Early predictors of oxaliplatin-induced cumulative neuropathy in colorectal cancer patients.

20. Attenuating effect of standardized fruit extract of Punica granatum L in rat model of tibial and sural nerve transection induced neuropathic pain.

21. TRPA1 insensitivity of human sural nerve axons after exposure to lidocaine.

22. Differential expression of neuregulin-1 isoforms and downregulation of erbin are associated with Erb B2 receptor activation in diabetic peripheral neuropathy.

23. Peptidergic CGRPα primary sensory neurons encode heat and itch and tonically suppress sensitivity to cold.

24. Comparison of the effects of new folkloric hemostatic agent on peripheral nerve function: an electrophysiologic study in rats.

25. Activation of axonal Kv7 channels in human peripheral nerve by flupirtine but not placebo - therapeutic potential for peripheral neuropathies: results of a randomised controlled trial.

26. Clinical grade cultivation of human Schwann cell, by the using of human autologous serum instead of fetal bovine serum and without growth factors.

27. Combination of alpha lipoic acid and superoxide dismutase leads to physiological and symptomatic improvements in diabetic neuropathy.

28. Characterization of oxaliplatin-induced chronic painful peripheral neuropathy in the rat and comparison with the neuropathy induced by paclitaxel.

29. Occupational exposure to pesticides and nerve conduction studies among Korean farmers.

30. Effects of perineural tramadol on nerve conduction of sural nerve.

31. Enhancement of axonal potassium conductance reduces nerve hyperexcitability in an in vitro model of oxaliplatin-induced acute neuropathy.

32. Millimeter wave effects on electrical responses of the sural nerve in vivo.

33. Phenylephrine suppresses the pain modulation of diffuse noxious inhibitory control in rats.

34. Rho kinase inhibitor Y-27632 facilitates recovery from experimental peripheral neuropathy induced by anti-cancer drug cisplatin.

35. The Kv7 potassium channel activator flupirtine affects clinical excitability parameters of myelinated axons in isolated rat sural nerve.

36. Sensory testing of distal sural and posterior tibial nerves provides early prediction of surgical anesthesia after single-injection infragluteal-parabiceps sciatic nerve block.

37. Ameliorative potential of pralidoxime in tibial and sural nerve transection-induced neuropathic pain in rats.

38. Effects of the antiepileptic drugs on peripheral nerve function.

39. Low concentrations of amitriptyline inhibit nicotinic receptors in unmyelinated axons of human peripheral nerve.

40. Effects of N-acetyl-cysteine on the survival and regeneration of sural sensory neurons in adult rats.

41. Ranirestat for the management of diabetic sensorimotor polyneuropathy.

42. Thirteen-month inhibition of aldose reductase by zenarestat prevents morphological abnormalities in the dorsal root ganglia of streptozotocin-induced diabetic rats.

43. Thalidomide and sensory neurotoxicity: a neurophysiological study.

44. Electrophysiological study in 2 children with transient hypohidrosis induced by topiramate.

45. Retigabine reduces the excitability of unmyelinated peripheral human axons.

46. Polyneuropathy induced by n-hexane intoxication in Taiwan.

47. Treatment with statins and involvement of the peripheral nervous system: results of a prospective clinical and neurophysiological follow-up.

48. Case of mononeuritis multiplex onset with rituximab therapy for Waldenström's macroglobulinemia.

49. Functional and morphological effects of repeated sodium arsenite exposure on rat peripheral sensory nerves.

50. Topiramate and physiologic measures of nerve function in polyneuropathy.